Back to Agendas
Late Breaking Addition: Introduction and Remarks from the New Deputy Commissioner of the FDA
Session Chair(s)
Lisa LaVange, PhD
Professor Emerita
University of North Carolina at Chapel Hill, United States
Speaker(s)
Robert M. Califf, MD
FDA, United States
Commissioner
Have an account?